{
    "organizations": [],
    "uuid": "da8a429a7db600a282fc886bad4dbc666b5f0caf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-a1m-pharma-applies-for-clinical-ph/brief-a1m-pharma-applies-for-clinical-phase-i-study-idUSFWN1PQ0ZJ",
    "ord_in_thread": 0,
    "title": "BRIEF-A1M Pharma Applies For Clinical Phase I Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - A1M PHARMA AB:\n* A1M PHARMA SUBMITS APPLICATION TO THE SWEDISH MEDICAL PRODUCTS AGENCY TO CONDUCT CLINICAL PHASE I STUDY WITH ROSGARDâ„¢ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-31T21:04:00.000+02:00",
    "crawled": "2018-02-01T15:06:47.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "a1m",
        "pharma",
        "ab",
        "a1m",
        "pharma",
        "submits",
        "application",
        "swedish",
        "medical",
        "product",
        "agency",
        "conduct",
        "clinical",
        "phase",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}